肺癌治疗的新策略：类花生酸的调节 - Suppr

Suppr

超能文献

Novel strategies for the treatment of lung cancer: modulation of eicosanoids.

作者信息

Backlund Michael G, Amann Joseph M, Johnson David H

出版信息

J Clin Oncol. 2008 Feb 20;26(6):825-7. doi: 10.1200/JCO.2007.14.9583.

DOI:10.1200/JCO.2007.14.9583

PMID:18281650

Abstract

摘要

相似文献

Novel strategies for the treatment of lung cancer: modulation of eicosanoids.

J Clin Oncol. 2008 Feb 20;26(6):825-7. doi: 10.1200/JCO.2007.14.9583.

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

J Clin Oncol. 2008 Feb 20;26(6):848-55. doi: 10.1200/JCO.2007.13.8081.

Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.

J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.

Targeting the eicosanoid pathway in non-small-cell lung cancer.

Expert Opin Ther Targets. 2009 Jun;13(6):675-88. doi: 10.1517/14728220902915567. Epub 2009 May 2.

Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.

Clin Cancer Res. 2005 Jun 1;11(11):4191-7. doi: 10.1158/1078-0432.CCR-05-0108.

Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.

Pharm Res. 2013 May;30(5):1435-46. doi: 10.1007/s11095-013-0984-9. Epub 2013 Jan 30.

Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.

J Clin Oncol. 2007 Sep 20;25(27):4318-20; author reply 4320. doi: 10.1200/JCO.2007.12.2945.

Did targeted therapy fail cyclooxygenase too?

J Clin Oncol. 2006 Oct 20;24(30):4798-800. doi: 10.1200/JCO.2006.08.0622.

Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.

Am J Hematol. 2006 Apr;81(4):242-55. doi: 10.1002/ajh.20542.

Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells.

Mol Cancer Ther. 2005 Sep;4(9):1358-63. doi: 10.1158/1535-7163.MCT-05-0139.

引用本文的文献

Elevation of prostaglandin E2 in lung cancer patients with digital clubbing.

J Thorac Oncol. 2012 Dec;7(12):1877-1878. doi: 10.1097/JTO.0b013e3181fc76a9.

Targeting the eicosanoid pathway in non-small-cell lung cancer.

Expert Opin Ther Targets. 2009 Jun;13(6):675-88. doi: 10.1517/14728220902915567. Epub 2009 May 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Novel strategies for the treatment of lung cancer: modulation of eicosanoids.

作者信息

Backlund Michael G, Amann Joseph M, Johnson David H

出版信息

J Clin Oncol. 2008 Feb 20;26(6):825-7. doi: 10.1200/JCO.2007.14.9583.

DOI:10.1200/JCO.2007.14.9583

PMID:18281650

Abstract

摘要

相似文献

Novel strategies for the treatment of lung cancer: modulation of eicosanoids.

J Clin Oncol. 2008 Feb 20;26(6):825-7. doi: 10.1200/JCO.2007.14.9583.

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

J Clin Oncol. 2008 Feb 20;26(6):848-55. doi: 10.1200/JCO.2007.13.8081.

Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.

J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.

Targeting the eicosanoid pathway in non-small-cell lung cancer.

Expert Opin Ther Targets. 2009 Jun;13(6):675-88. doi: 10.1517/14728220902915567. Epub 2009 May 2.

Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.

Clin Cancer Res. 2005 Jun 1;11(11):4191-7. doi: 10.1158/1078-0432.CCR-05-0108.

Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.

Pharm Res. 2013 May;30(5):1435-46. doi: 10.1007/s11095-013-0984-9. Epub 2013 Jan 30.

Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.

J Clin Oncol. 2007 Sep 20;25(27):4318-20; author reply 4320. doi: 10.1200/JCO.2007.12.2945.

Did targeted therapy fail cyclooxygenase too?

J Clin Oncol. 2006 Oct 20;24(30):4798-800. doi: 10.1200/JCO.2006.08.0622.

Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.

Am J Hematol. 2006 Apr;81(4):242-55. doi: 10.1002/ajh.20542.

Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells.

Mol Cancer Ther. 2005 Sep;4(9):1358-63. doi: 10.1158/1535-7163.MCT-05-0139.

引用本文的文献

Elevation of prostaglandin E2 in lung cancer patients with digital clubbing.

J Thorac Oncol. 2012 Dec;7(12):1877-1878. doi: 10.1097/JTO.0b013e3181fc76a9.

Targeting the eicosanoid pathway in non-small-cell lung cancer.

Expert Opin Ther Targets. 2009 Jun;13(6):675-88. doi: 10.1517/14728220902915567. Epub 2009 May 2.